Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2000
04/06/2000WO2000018888A1 Immunomodulation by genetic modification of dendritic cells and b-cells
04/06/2000WO2000018886A1 Xenobiotic detoxification gene from plants
04/06/2000WO2000018885A1 Methods of controlling proliferation and differentiation of stem and progenitor cells
04/06/2000WO2000018881A2 Intein mediated peptide ligation
04/06/2000WO2000018880A2 Inhibition of farnesyltransferase activity in plants
04/06/2000WO2000018804A1 Tie2 agonist antibodies
04/06/2000WO2000018803A2 Antibodies to mammalian langerhans cell antigen and their uses
04/06/2000WO2000018801A2 Ncam binding compounds
04/06/2000WO2000018799A1 Artemin, a novel neurotrophic factor
04/06/2000WO2000018797A1 Map
04/06/2000WO2000018796A2 Secretory protein- zsig48
04/06/2000WO2000018795A2 Compositions and methods for wt1 specific immunotherapy
04/06/2000WO2000018786A1 Antisense modulation of rip-1 expression
04/06/2000WO2000018785A1 Antisense modulation of cd71 expression
04/06/2000WO2000018784A1 ANTISENSE MODULATION OF RhoG EXPRESSION
04/06/2000WO2000018783A1 Mammaglobin, a secreted mammary-specific breast cancer protein
04/06/2000WO2000018782A2 Hrpca 9 and hrpca 10 nucleic acids and polypeptides
04/06/2000WO2000018438A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof
04/06/2000WO2000018437A1 Tie2 antagonist antibodies
04/06/2000WO2000018434A1 Mutant cholera holotoxin as an adjuvant
04/06/2000WO2000018426A1 Apoptosis inducers
04/06/2000WO2000018421A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions
04/06/2000WO2000018351A2 Aglyco products and methods of use
04/06/2000WO2000018240A1 Gene delivery system and methods of use
04/06/2000WO2000018212A2 Platelet-derived growth factor c, dna coding therefor, and uses thereof
04/06/2000WO2000006735A8 Interferon alpha hybrids
04/06/2000WO2000006588B1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS
04/06/2000WO2000004051A9 Growth differentiation factor promoter and uses therefor
04/06/2000WO2000001850A3 Molecular torches
04/06/2000WO2000001835A3 Targeted integration into chromosomes using retroviral vectors
04/06/2000WO2000001826A3 Stabilized variants of streptomyces subtilisin inhibitor
04/06/2000WO1999067628A9 Multi-sensor array for electrochemical recognition of nucleotide sequences and methods
04/06/2000WO1999067384A3 Prostate cancer-associated genes
04/06/2000WO1999066324A3 A bioluminescence resonance energy transfer (bret) system and its use
04/06/2000WO1999066058A9 Materials and methods for amplifying and enhanced transcribing of polynucleotides in plants and portions thereof
04/06/2000WO1999066054A3 Erythropoietin analog-human serum albumin fusion protein
04/06/2000WO1999066035A3 Vector construction by host cell-mediated recombination
04/06/2000WO1999065938A3 Fy7 polymerase
04/06/2000WO1999064596A3 Proteins regulating gene expression
04/06/2000WO1999064585A3 Novel angiotensin receptor, production and use thereof
04/06/2000WO1999064584A3 Protein for regulating apoptosis
04/06/2000WO1999064582A3 High-throughput screening of gene function using libraries for functional genomics applications
04/06/2000WO1999063097A3 Caspase-9 deficient animals and the use thereof
04/06/2000WO1999063092A9 Root-specific protein involved in auxin transport
04/06/2000WO1999063082A3 Isolation of drosophila homolog to mammalian gdnf
04/06/2000WO1999063074A3 Altering the ligand-binding characteristics of a nucleic acid ligand binding sequence by altering the nucleotide composition of its flanking sequences
04/06/2000WO1999062944A3 Protein oligomer compositions comprising endostatin protein and methods of using the same
04/06/2000WO1999062941A3 Serpentine transmembrane antigens expressed in human cancers and uses thereof
04/06/2000WO1999061626A3 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase
04/06/2000WO1999061618A3 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
04/06/2000WO1999061610A3 TUMOUR SUPPRESSOR GENES OF THE p53 FAMILY
04/06/2000WO1999061468A3 The induction of antibiotic peptides by lait (scd14) protein
04/06/2000WO1999061453A3 priA
04/06/2000WO1999059190A3 Process and manufacturing tool architecture for use in the manufacture of one or more metallization levels on a workpiece
04/06/2000WO1999058699A3 Transgenic plant-derived human blood coagulation factors
04/06/2000WO1999058698A3 Heat stable mutants of starch biosynthesis enzymes
04/06/2000WO1999058683A3 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS)
04/06/2000WO1999058638A3 Sequences of tt viruses for use in diagnosis, prevention and treatment of ttv infections
04/06/2000WO1999057325A3 Enzymes mixture
04/06/2000WO1999057144A3 Human transcriptional regulator molecules
04/06/2000WO1999055891A9 Plant gene that regulates dna methylation
04/06/2000WO1999055889A3 Carotenoid biosynthesis enzymes
04/06/2000WO1999055730A3 Polyepitope carrier protein
04/06/2000WO1999055564A9 Materials and methods for gene therapy
04/06/2000WO1999055132A3 Generation of packaging system for human recombinant adenoviral vectors
04/06/2000WO1999053051A3 5' ests and encoded human proteins
04/06/2000WO1999053042A3 Biological material with increased expression of endogenous complement regulatory molecules
04/06/2000WO1999051748A9 Fusion proteins of mycobacterium tuberculosis antigens and their uses
04/06/2000WO1999051625A3 Peptides causing formation of compact structures
04/06/2000WO1999049058A3 Tryptophan biosynthetic enzymes
04/06/2000WO1999046284A3 Molecules that home to various selected organs or tissues
04/06/2000WO1999038972A8 Human genes and gene expression products ii
04/06/2000WO1998050549A3 Two human g-protein coupled receptors: ebv-induced gpcr 2 (ebi-2) and edg-1-like gpcr
04/06/2000WO1998046776A3 Plant fatty acid synthases and use in improved methods for production of medium-chain fatty acids
04/06/2000WO1997035960A8 Purified proteins, recombinant dna sequences and processes for producing caffeine free beverages
04/06/2000DE19923567A1 Gene des 1-Desoxy-D-xylulose-Biosynthesewegs Genes of the 1-deoxy-D-xylulose pathway
04/06/2000DE19845231A1 Use of DNA encoding 1-deoxy-D-xylulose-5-phosphate synthase to produce plants with increased tocopherol, vitamin K, chlorophyll and carotenoid content
04/06/2000DE19845224A1 Use of DNA encoding 1-deoxy-D-xylulose-5-phosphate synthase to produce plants with increased tocopherol, vitamin K, chlorophyll and carotenoid content
04/06/2000DE19845216A1 Use of DNA encoding 1-deoxy-D-xylulose-5-phosphate synthase to produce plants with increased tocopherol, vitamin K, chlorophyll and carotenoid content
04/06/2000CA2348548A1 Method for dna- or rna-sequencing
04/06/2000CA2344766A1 Antibodies to mammalian langerhans cell antigen and their uses
04/06/2000CA2344763A1 Human carbohydrate-associated proteins
04/06/2000CA2344742A1 Nucleic acids and proteins from cenarchaeum symbiosum
04/06/2000CA2344714A1 Hrpca 9 and hrpca 10 nucleic acids and polypeptides
04/06/2000CA2344712A1 Secretory protein- zsig48
04/06/2000CA2344658A1 Human kinesin-like motor protein
04/06/2000CA2344653A1 Methods of controlling proliferation and differentiation of stem and progenitor cells
04/06/2000CA2344622A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof
04/06/2000CA2344620A1 Gene expressed in prostate cancer
04/06/2000CA2344578A1 Polistinae venom phospholipase
04/06/2000CA2344575A1 Methods of nucleic acid amplification and sequencing
04/06/2000CA2344561A1 Platelet-derived growth factor c, dna coding therefor, and uses thereof
04/06/2000CA2344550A1 Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
04/06/2000CA2344464A1 Dnas encoding novel polypeptides
04/06/2000CA2344458A1 Novel enzyme composition and production method and use thereof
04/06/2000CA2344457A1 Slgp protein and nucleic acid molecule and uses therefor
04/06/2000CA2344282A1 An in vitro activity assay for human hepatitis b virus (hbv) dna polymerase, and its use for screening for inhibitors of hbv dna polymerase
04/06/2000CA2344274A1 Angiotensin converting enzyme homolog and its use
04/06/2000CA2344107A1 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases
04/06/2000CA2344104A1 Method of screening for large offspring syndrome
1 ... 3262 3263 3264 3265 3266 3267 3268 3269 3270 3271 3272 3273 3274 3275 3276 3277 3278 3279 3280 3281 3282 ... 4023